Physician profile
Eric James Rebich
NPI 1841639317
$59,704.87
in general payments reported to CMS, 2019-2025
24 companies · $8,959 in 2025
The $8,959 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $318 · 2021: $4,227 · 2022: $20K · 2023: $25K · 2024: $830 · 2025: $8,959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,600 · Travel and Lodging: $3,877 · Food and Beverage: $3,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,600.00 |
| Travel and Lodging | $3,877.23 |
| Food and Beverage | $3,560.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $49,388.44 | 2021-2025 | Creo Mis Stabilization System, Xlif, Elsa, Elsa Al/Atp |
| Abbott Laboratories | $3,477.58 | 2019-2025 | Proclaim, Octrode, Penta |
| Cerapedics INC. | $2,100.33 | 2021 | |
| Centinel Spine, LLC | $647.60 | 2021-2022 | |
| Medtronic, INC. | $527.11 | 2021-2025 | Catalyft Pl Expandable Interbody System, Unid_pass, Intellis Adaptivestim |
| Nevro Corp. | $391.56 | 2021-2024 | Senza |
| Nalu Medical, INC. | $382.72 | 2021-2024 | Nalu Neurostimulation System |
| Stryker Corporation | $352.11 | 2020-2025 | Insignia |
| Si-Bone, INC. | $307.86 | 2022-2024 | |
| Boston Scientific Corporation | $272.92 | 2021-2025 | Wavewriter Alpha Prime 16, Avista Mri |
| Arthrex, INC. | $242.68 | 2025 | |
| Kerecis Limited | $234.24 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Impactortho, INC. | $226.34 | 2025 | |
| Depuy Synthes Sales INC. | $213.98 | 2019-2022 | |
| Highridge Medical LLC | $196.27 | 2024-2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System, Mobi-C Plug & Fit US |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $165.05 | 2019-2021 | |
| Providence Medical Technology, INC. | $149.72 | 2025 | |
| Terumo Bct, INC. | $130.44 | 2022 | |
| Seaspine Orthopedics Corporation | $111.99 | 2021 | |
| Orthofix Medical, INC. | $79.13 | 2020-2024 | Physio-Stim |
| 4web, INC. | $55.65 | 2019 | |
| Radius Health, INC. | $27.99 | 2020 | |
| Janssen Pharmaceuticals, INC | $23.16 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rebich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.